Status:
RECRUITING
Exploration of Noninvasive Differential Diagnosis of Benign and Malignant Liver Tumors
Lead Sponsor:
Xijing Hospital
Conditions:
Liver Tumor
Eligibility:
All Genders
18-70 years
Brief Summary
To explore an effective noninvasive method for differential diagnosis of liver tumors.
Detailed Description
A retrospective study was performed to assess the performance of certain ultrasound-based parameters, in distinguishing benign from malignant with liver biopsy as the gold standard. Demographic data, ...
Eligibility Criteria
Inclusion
- (1) age 18-70 years; (2) liver examination performed for all patients prior to US-guided liver biopsy or surgery; (3) tumor can be visualized in conventional US; (4) largest tumor sectional area saved in DICOM format for use in later analyses; (5) a histopathological diagnosis made either from US-guided liver biopsy or surgical resection; (6) suitable routine clinical and US data obtained within 7 days of the histopathological diagnosis.
Exclusion
- (1) unavailable pathological diagnosis; (2) liver metastatic tumors; (3) poor quality US images; and (4) a past history of surgical resection, percutaneous local ablation, radiation, transarterial and systemic therapies or liver transplantation.
Key Trial Info
Start Date :
January 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2025
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06524557
Start Date
January 1 2018
End Date
December 30 2025
Last Update
July 29 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Xijing Hosptial
Xi'an, Xi'an, China, 710032